Literature DB >> 31974140

Troponin T Parallels Structural Nerve Damage in Type 2 Diabetes: A Cross-sectional Study Using Magnetic Resonance Neurography.

Johann M E Jende1, Jan B Groener2,3, Zoltan Kender2, Artur Hahn1, Jakob Morgenstern2, Sabine Heiland1, Peter P Nawroth2,3,4, Martin Bendszus1, Stefan Kopf2,3, Felix T Kurz5.   

Abstract

Clinical studies have suggested that changes in peripheral nerve microcirculation may contribute to nerve damage in diabetic polyneuropathy (DN). High-sensitivity troponin T (hsTNT) assays have been recently shown to provide predictive values for both cardiac and peripheral microangiopathy in type 2 diabetes (T2D). This study investigated the association of sciatic nerve structural damage in 3 Tesla (3T) magnetic resonance neurography (MRN) with hsTNT and N-terminal pro-brain natriuretic peptide serum levels in patients with T2D. MRN at 3T was performed in 51 patients with T2D (23 without DN, 28 with DN) and 10 control subjects without diabetes. The sciatic nerve's fractional anisotropy (FA), a marker of structural nerve integrity, was correlated with clinical, electrophysiological, and serological data. In patients with T2D, hsTNT showed a negative correlation with the sciatic nerve's FA (r = -0.52, P < 0.001), with a closer correlation in DN patients (r = -0.66, P < 0.001). hsTNT further correlated positively with the neuropathy disability score (r = 0.39, P = 0.005). Negative correlations were found with sural nerve conduction velocities (NCVs) (r = -0.65, P < 0.001) and tibial NCVs (r = -0.44, P = 0.002) and amplitudes (r = -0.53, P < 0.001). This study is the first to show that hsTNT is a potential indicator for structural nerve damage in T2D. Our results indirectly support the hypothesis that microangiopathy contributes to structural nerve damage in T2D.
© 2020 by the American Diabetes Association.

Entities:  

Year:  2020        PMID: 31974140     DOI: 10.2337/db19-1094

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  12 in total

1.  Sciatic nerve microvascular permeability in type 2 diabetes decreased in patients with neuropathy.

Authors:  Johann M E Jende; Christoph Mooshage; Zoltan Kender; Lukas Schimpfle; Alexander Juerchott; Sabine Heiland; Peter Nawroth; Martin Bendszus; Stefan Kopf; Felix T Kurz
Journal:  Ann Clin Transl Neurol       Date:  2022-04-30       Impact factor: 5.430

2.  Diffusion Tensor Imaging of the Sciatic Nerve as a Surrogate Marker for Nerve Functionality of the Upper and Lower Limb in Patients With Diabetes and Prediabetes.

Authors:  Johann M E Jende; Zoltan Kender; Christoph Mooshage; Jan B Groener; Lucia Alvarez-Ramos; Jennifer Kollmer; Alexander Juerchott; Artur Hahn; Sabine Heiland; Peter Nawroth; Martin Bendszus; Stefan Kopf; Felix T Kurz
Journal:  Front Neurosci       Date:  2021-03-03       Impact factor: 4.677

3.  Fractional Anisotropy and Troponin T Parallel Structural Nerve Damage at the Upper Extremities in a Group of Patients With Prediabetes and Type 2 Diabetes - A Study Using 3T Magnetic Resonance Neurography.

Authors:  Johann M E Jende; Zoltan Kender; Jakob Morgenstern; Pascal Renn; Christoph Mooshage; Alexander Juerchott; Stefan Kopf; Peter P Nawroth; Martin Bendszus; Felix T Kurz
Journal:  Front Neurosci       Date:  2022-01-24       Impact factor: 4.677

4.  MRI DTI and PDFF as Biomarkers for Lower Motor Neuron Degeneration in ALS.

Authors:  Thorsten Lichtenstein; Alina Sprenger; Kilian Weiss; Nils Große Hokamp; David Maintz; Marc Schlamann; Gereon R Fink; Helmar C Lehmann; Tobias D Henning
Journal:  Front Neurosci       Date:  2021-08-26       Impact factor: 4.677

5.  Magnetic Resonance Imaging as a Biomarker in Diabetic and HIV-Associated Peripheral Neuropathy: A Systematic Review-Based Narrative.

Authors:  Matthew C Evans; Charles Wade; David Hohenschurz-Schmidt; Pete Lally; Albert Ugwudike; Kamal Shah; Neal Bangerter; David J Sharp; Andrew S C Rice
Journal:  Front Neurosci       Date:  2021-09-21       Impact factor: 4.677

6.  Neuron-specific biomarkers predict hypo- and hyperalgesia in individuals with diabetic peripheral neuropathy.

Authors:  Jakob Morgenstern; Jan B Groener; Johann M E Jende; Felix T Kurz; Alexander Strom; Jens Göpfert; Zoltan Kender; Maxime Le Marois; Maik Brune; Rohini Kuner; Stephan Herzig; Michael Roden; Dan Ziegler; Martin Bendszus; Julia Szendroedi; Peter Nawroth; Stefan Kopf; Thomas Fleming
Journal:  Diabetologia       Date:  2021-09-03       Impact factor: 10.122

7.  Magnetic Resonance Neurography Reveals Smoking-Associated Decrease in Sciatic Nerve Structural Integrity in Type 2 Diabetes.

Authors:  Johann M E Jende; Christoph Mooshage; Zoltan Kender; Stefan Kopf; Jan B Groener; Sabine Heiland; Alexander Juerchott; Peter Nawroth; Martin Bendszus; Felix T Kurz
Journal:  Front Neurosci       Date:  2022-02-15       Impact factor: 4.677

8.  Assessing Lumbar Plexus and Sciatic Nerve Damage in Relapsing-Remitting Multiple Sclerosis Using Magnetisation Transfer Ratio.

Authors:  Ratthaporn Boonsuth; Rebecca S Samson; Carmen Tur; Marco Battiston; Francesco Grussu; Torben Schneider; Masami Yoneyama; Ferran Prados; Antrea Ttofalla; Sara Collorone; Rosa Cortese; Olga Ciccarelli; Claudia A M Gandini Wheeler-Kingshott; Marios C Yiannakas
Journal:  Front Neurol       Date:  2021-11-25       Impact factor: 4.003

9.  Serum Troponin T Concentrations Are Frequently Elevated in Advanced Skin Cancer Patients Prior to Immune Checkpoint Inhibitor Therapy: Experience From a Single Tertiary Referral Center.

Authors:  Jonas K Kurzhals; Tobias Graf; Katharina Boch; Ulrike Grzyska; Alex Frydrychowicz; Detlef Zillikens; Patrick Terheyden; Ewan A Langan
Journal:  Front Med (Lausanne)       Date:  2021-07-05

10.  Diabetes Increases the Vulnerability of the Cardiac Mitochondrial Network to Criticality.

Authors:  Larissa Vetter; Sonia Cortassa; Brian O'Rourke; Antonis A Armoundas; Djahida Bedja; Johann M E Jende; Martin Bendszus; Nazareno Paolocci; Steven J Sollot; Miguel A Aon; Felix T Kurz
Journal:  Front Physiol       Date:  2020-03-10       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.